ID   S12A1_RAT               Reviewed;        1095 AA.
AC   P55016;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-OCT-2024, entry version 143.
DE   RecName: Full=Solute carrier family 12 member 1;
DE   AltName: Full=Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 {ECO:0000303|PubMed:8021284};
DE            Short=BSC1;
DE   AltName: Full=Kidney-specific Na-K-Cl symporter;
DE   AltName: Full=Na-K-2Cl cotransporter 2;
DE            Short=NKCC2;
GN   Name=Slc12a1; Synonyms=Nkcc2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORT ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8021284; DOI=10.1016/s0021-9258(17)32499-7;
RA   Gamba G., Miyanoshita A., Lombardi M., Lytton J., Lee W.S., Hediger M.A.,
RA   Hebert S.C.;
RT   "Molecular cloning, primary structure, and characterization of two members
RT   of the mammalian electroneutral sodium-(potassium)-chloride cotransporter
RT   family expressed in kidney.";
RL   J. Biol. Chem. 269:17713-17722(1994).
RN   [2]
RP   PHOSPHORYLATION AT SER-126.
RX   PubMed=17341212; DOI=10.1042/bj20061850;
RA   Fraser S.A., Gimenez I., Cook N., Jennings I., Katerelos M., Katsis F.,
RA   Levidiotis V., Kemp B.E., Power D.A.;
RT   "Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-
RT   activated protein kinase (AMPK).";
RL   Biochem. J. 405:85-93(2007).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-114; SER-116 AND SER-144, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   INTERACTION WITH PPP3CB, TISSUE SPECIFICITY, AND MUTAGENESIS OF THR-96;
RP   THR-101 AND THR-114.
RX   PubMed=25967121; DOI=10.1681/asn.2014070728;
RA   Borschewski A., Himmerkus N., Boldt C., Blankenstein K.I., McCormick J.A.,
RA   Lazelle R., Willnow T.E., Jankowski V., Plain A., Bleich M., Ellison D.H.,
RA   Bachmann S., Mutig K.;
RT   "Calcineurin and sorting-related receptor with A-type repeats interact to
RT   regulate the renal Na(+)-K(+)-2Cl(-) cotransporter.";
RL   J. Am. Soc. Nephrol. 27:107-119(2016).
CC   -!- FUNCTION: Renal sodium, potassium and chloride ion cotransporter that
CC       mediates the transepithelial NaCl reabsorption in the thick ascending
CC       limb and plays an essential role in the urinary concentration and
CC       volume regulation. Electrically silent transporter system.
CC       {ECO:0000269|PubMed:8021284, ECO:0000305|PubMed:25967121}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 chloride(out) + K(+)(out) + Na(+)(out) = 2 chloride(in) +
CC         K(+)(in) + Na(+)(in); Xref=Rhea:RHEA:72395, ChEBI:CHEBI:17996,
CC         ChEBI:CHEBI:29101, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:8021284};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72396;
CC         Evidence={ECO:0000305|PubMed:8021284};
CC   -!- ACTIVITY REGULATION: Activated following phosphorylation by OXSR1/OSR1
CC       and STK39/SPAK downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4).
CC       {ECO:0000250|UniProtKB:Q13621}.
CC   -!- SUBUNIT: When phosphorylated, interacts with PPP3CB.
CC       {ECO:0000269|PubMed:25967121}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000250|UniProtKB:P55014}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in kidney (at protein
CC       level). {ECO:0000269|PubMed:25967121, ECO:0000269|PubMed:8021284}.
CC   -!- DOMAIN: The RFXV motif mediates binding with OXSR1/OSR1 and STK39/SPAK.
CC       {ECO:0000250|UniProtKB:Q13621}.
CC   -!- PTM: Phosphorylated at Ser-87, Thr-96 and Thr-101 by OXSR1/OSR1 and
CC       STK39/SPAK downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4),
CC       promoting its activity. {ECO:0000250|UniProtKB:Q13621}.
CC   -!- SIMILARITY: Belongs to the SLC12A transporter family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10096; AAA21251.1; -; mRNA.
DR   PIR; A54145; A54145.
DR   AlphaFoldDB; P55016; -.
DR   SMR; P55016; -.
DR   STRING; 10116.ENSRNOP00000073076; -.
DR   TCDB; 2.A.30.1.1; the cation-chloride cotransporter (ccc) family.
DR   GlyCosmos; P55016; 2 sites, No reported glycans.
DR   GlyGen; P55016; 2 sites.
DR   iPTMnet; P55016; -.
DR   PhosphoSitePlus; P55016; -.
DR   PaxDb; 10116-ENSRNOP00000008857; -.
DR   UCSC; RGD:3685; rat.
DR   AGR; RGD:3685; -.
DR   RGD; 3685; Slc12a1.
DR   eggNOG; KOG2083; Eukaryota.
DR   InParanoid; P55016; -.
DR   PhylomeDB; P55016; -.
DR   Reactome; R-RNO-426117; Cation-coupled Chloride cotransporters.
DR   PRO; PR:P55016; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0008511; F:sodium:potassium:chloride symporter activity; IDA:RGD.
DR   GO; GO:0006884; P:cell volume homeostasis; ISO:RGD.
DR   GO; GO:0055064; P:chloride ion homeostasis; IBA:GO_Central.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IDA:RGD.
DR   GO; GO:0016101; P:diterpenoid metabolic process; IEP:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0055075; P:potassium ion homeostasis; IBA:GO_Central.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:0032978; P:protein insertion into membrane from inner side; IDA:RGD.
DR   GO; GO:0070294; P:renal sodium ion absorption; IC:BHF-UCL.
DR   GO; GO:0055078; P:sodium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   GO; GO:0071918; P:urea transmembrane transport; ISO:RGD.
DR   Gene3D; 1.20.1740.10; Amino acid/polyamine transporter I; 1.
DR   InterPro; IPR004841; AA-permease/SLC12A_dom.
DR   InterPro; IPR013612; AA_permease_N.
DR   InterPro; IPR018491; SLC12_C.
DR   InterPro; IPR002445; Slc12a1.
DR   InterPro; IPR002443; SLC12A1/SLC12A2.
DR   InterPro; IPR004842; SLC12A_fam.
DR   NCBIfam; TIGR00930; 2a30; 1.
DR   PANTHER; PTHR11827:SF93; SOLUTE CARRIER FAMILY 12 MEMBER 1; 1.
DR   PANTHER; PTHR11827; SOLUTE CARRIER FAMILY 12, CATION COTRANSPORTERS; 1.
DR   Pfam; PF00324; AA_permease; 1.
DR   Pfam; PF08403; AA_permease_N; 1.
DR   Pfam; PF03522; SLC12; 1.
DR   PRINTS; PR01207; NAKCLTRNSPRT.
DR   PRINTS; PR01209; NAKCLTRSPRT2.
PE   1: Evidence at protein level;
KW   Cell membrane; Chloride; Glycoprotein; Ion transport; Membrane;
KW   Phosphoprotein; Potassium; Potassium transport; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1095
FT                   /note="Solute carrier family 12 member 1"
FT                   /id="PRO_0000178021"
FT   TOPO_DOM        1..173
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        174..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        195..197
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        198..218
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        219..255
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        256..276
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        277..298
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        299..319
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..323
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        324..344
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        345..375
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        376..396
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        397..413
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        414..434
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        435..546
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        547..567
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        568..588
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        589..605
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        606..626
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        627..1095
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          26..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           16..19
FT                   /note="RFXV motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q13621"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55014"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13621"
FT   MOD_RES         91
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13621"
FT   MOD_RES         96
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55014"
FT   MOD_RES         101
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55014"
FT   MOD_RES         114
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         126
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:17341212"
FT   MOD_RES         144
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        442
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        452
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         96
FT                   /note="T->A: Loss of interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
FT   MUTAGEN         96
FT                   /note="T->D: No effect on interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
FT   MUTAGEN         101
FT                   /note="T->A: Loss of interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
FT   MUTAGEN         101
FT                   /note="T->D: No effect on interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
FT   MUTAGEN         114
FT                   /note="T->A: Loss of interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
FT   MUTAGEN         114
FT                   /note="T->D: No effect on interaction with PPP3CB."
FT                   /evidence="ECO:0000269|PubMed:25967121"
SQ   SEQUENCE   1095 AA;  120597 MW;  93C46F6ACD44363C CRC64;
     MSVNIPSNSV PSGASRFQVH VINEGHGSGA AMSDSTDPPH YEETSFGDEA QNRLKISFRP
     GNQECYENFL QTGETAKTDT TFHAYDSHTN TYYLQTFGHN TMDAVPKIEY YRNTGSVSGP
     KVNRPSLQEI HEQLAKNVAV APGSADRVAN GDGMPGDEQA ENKEEDVTGV VKFGWVKGVL
     VRCMLNIWGV MLFIRLSWIV GEAGIGLGVI IIGLSVVVTT LTGISMSAIC TNGVVRGGGA
     YYLISRSLGP EFGGSIGLIF RFANAVRVAM YVVGFAETVV DLLKESDSMM VDPTNDIRII
     GSITVVILLG ISVAGMEWEA KAQVILLVIL LIGIANFFIG TVIPSNNEKK SRGFFNYQAS
     IFAENFGPSF TEGEGFFSVF AIFFPAATGI LAGANISGDL EDPQDAIPRG TMLAIFITTV
     AYIGVAICVR ACVVRDATGS MNDTVVSGMN CNGSAACGLG YDFSRCQHEP CQYGLMNNFQ
     VMSMVSGFGP LITAGIFSAT LSSALASLVS APKVFQALCK DNIFKGLQFF AKGYGKNNEP
     LRGYFLTFVI AMAFILIAEL NVIAPIISNF FLASYALINF SCFHASYAKS PGWRPAYGIY
     NMWVSLFGAI LCCAVMFVIN WWAAVITYVI ELFLYIYVTY KKPDVNWGSS TQALSYVSAL
     DNALELTTVE DHVKNFRPQC IVLTGGPMTR PALLDITHAF TKNSGLCICC EVFVGPRKLC
     VKEMNSGMAK KQAWLMKNKI KAFYAAVAAD CFRDGVRSLL QASGLGRMKP NTLVIGYKKN
     WRKAPLSELE NYVGIIHDAF DFEIGVVIVR ISQGFDISPV LQVQDELEKL EQERLALEAA
     IKDNDCEEGK GGIRGLFKKA GKLNITKPAP KKDSNISTIQ SMHVGEFNQK LVEASAQFKK
     KQGKGTIDVW WLFDDGGLTL LIPYILTLRK KWKDCKLRIY VGGKINRIEE EKISMASLLS
     KFRIKFADIH IIGDINIKPN KESWKVFEEM IEPYRLHESH KDLTTAEKLK RESPWKITDA
     ELEAVKEKSY RQVRLNELLQ EHSRAANLIV LSLPVARKGS ISDLLYMAWL EILTKNLPPV
     LLVRGNHKNV LTFYS
//
